AbbVie CEO Upbeat On Skyrizi Commercialization, Raises Financial Guidance

 
• By John Davis
  
Steps
Product approvals and increasing revenues are buoying AbbVie, but biosimilar concerns with Humira remain • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip